Biogenerics Announces Financing Plan for the Hydroslotter Roll Out
October 18, 2005 10:34 ET
|
Biogenerics Limited
TORONTO, Oct. 18, 2005 (PRIMEZONE) -- Biogenerics Limited (Pink Sheets:BIGN): The company is pleased to announce that it has secured an agreement with an institutional investor Royal Petroleum. Royal...
CTR Investments to Design Systems to Locate and Rescue Missing Children for SaferKidz, a Virginia-Based Not-for-Profit
October 18, 2005 10:30 ET
|
CTR Investments & Consulting, Inc.
WASHINGTON, Oct. 18, 2005 (PRIMEZONE) -- CTR Investments and Consulting Inc. (Pink Sheets:CIVX) has been contracted to provide technical and procedural design and implementation services for...
Wavestream Corporation Unveils Its PowerStream 16-Watt Fanless Ku-Band Deck Block Upconverter 'BUC'
October 18, 2005 10:30 ET
|
Wavestream Corporation
ATLANTIC CITY, N.J., Oct. 18, 2005 (PRIMEZONE) -- Wavestream Corporation (www.wavestreamcorp.com), a manufacturer of a new generation of compact high-efficiency solid-state power amplifiers, today...
Delta to Become World's Largest Transatlantic Airline
October 18, 2005 10:30 ET
|
Delta Air Lines, Inc.
ATLANTA, Oct. 18, 2005 (PRIMEZONE) -- As part of the largest international expansion in its history, Delta Air Lines plans to begin non-stop, widebody service from its transatlantic gateways at...
Earnings Growth Continues Rapid Pace at Beach First
October 18, 2005 10:24 ET
|
Beach First National Bank
MYRTLE BEACH, S.C., Oct. 18, 2005 (PRIMEZONE) -- Beach First National Bancshares, Inc. (Nasdaq:BFNB) today announced that its third quarter earnings increased 109% over figures reported for...
Window Rock Capital Corp. Signs Definitive Real Estate Agreement with RPM Ventures, LLC
October 18, 2005 10:20 ET
|
Window Rock Capital Corp.
HOUSTON, Oct. 18, 2005 (PRIMEZONE) -- Window Rock Capital Corporation, (Pink Sheets:NWMN), a real estate asset development company, announced that it has entered into a definitive agreement with RPM...
UCB: Phase III study shows CIMZIA(TM) is an effective and well-tolerated treatment for Crohn's disease
October 18, 2005 10:00 ET
|
UCB
Copenhagen, Denmark, October 18, 2005 - UCB announced today at the United European Gastroenterology Week the detailed Phase III study results (PRECiSE 2) for CIMZIA(TM) (certolizumab pegol, CDP870) in...
UCB - Fase III-onderzoek toont aan dat CIMZIA(TM) een doeltreffende en goed getolereerde behandeling voor de ziekte van Crohn is
October 18, 2005 10:00 ET
|
UCB
Kopenhagen, Denemarken, 18 oktober 2005 - UCB kondigde vandaag de gedetailleerde Fase III resultaten (PRECiSE 2) aan voor CIMZIA(TM) (certolizumab pego, CDP870) voor de behandeling van de ziekte...
UCB: Une étude de phase III montre que CIMZIA(TM) est un traitement efficace et bien toléré pour la maladie de Crohn
October 18, 2005 10:00 ET
|
UCB
Copenhague, Danemark, le 18 octobre 2005 - UCB a annoncé aujourd'hui les résultats détaillés de l'étude de phase 3 (PRECiSE 2) pour CIMZIA(TM) (certolizumab pegol, CDP870) pour le traitement de la...
AmeriCare Alliance's In-Home Care is a Compassionate, Affordable Option for Seniors
October 18, 2005 10:00 ET
|
AmeriCare Alliance of Oregon
PORTLAND, Ore., Oct. 18, 2005 (PRIMEZONE) -- All across America, families are faced with the challenge of caring for elders and ailing loved ones. In today's 'hurry-up' society, the task seems...
- July 28, 2024 22:56 ET Merevolusikan Dagangan CFD dengan Petunjuk Utama DiNapoli: EBC Financial Group Mengumumkan Perkongsian Strategik
- July 28, 2024 16:51 ET Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)